35 Crosby Drive
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging applications. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment and mini C-arm and extremity MRI imaging for orthopedic applications.
565 articles with Hologic
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has approved 3DQuorum™ Imaging Technology, powered by Genius AI™. 3DQuorum technology works in tandem with Hologic’s Clarity HD™ high resolution imaging technology to reduce tomosynthesis image volume for radiologists by 66 percent
Hologic, Inc. announced the Company’s financial results for the fiscal fourth quarter ended September 28, 2019.
Hologic Launches Definity Cervical Dilator to Provide Gentle and Seamless Dilation During Gynecologic Procedures
Physicians can now access a wide variety of uterine cavities effortlessly with innovative SureAccess balloon technology
Hologic points to hundreds of peer-reviewed clinical studies that consistently demonstrate improved outcomes with 3D mammography
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2019 on Wednesday, November 6, 2019
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2019 on Wednesday, November 6, 2019, after the market closes
World leader in breast cancer screening celebrates recent portfolio expansion to address the entire continuum of breast cancer diagnosis and care
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10 at 12:20 p.m. Eastern Time.
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Canaccord Genuity 39th Annual Growth Conference in New York, NY on Wednesday, August 7 at 10 a.m. Eastern Time.
Hologic Acquires Approximately 46% of Shares in SuperSonic Imagine, a French Innovator in Ultrasound Medical Imaging
Hologic, Inc. (Nasdaq : HOLX), a global leader in women’s health, and SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialized in ultrasound medical imaging, jointly announce today that Hologic Hub Ltd, a wholly-owned indirect subsidiary of Hologic, Inc., has acquired approximately 46% of SuperSonic Imagine shares, pursuant to a shares sale agreement entered into today.
Hologic, Inc. announced the Company’s financial results for the fiscal third quarter ended June 29, 2019.
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2019 on Wednesday, July 31, 2019
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2019 on Wednesday, July 31, 2019, after the market closes.
Hologic Enters into Exclusive Negotiations to Acquire SuperSonic Imagine, French Ultrasound Innovator
Transaction Will Strengthen Hologic’s Breast Health Product Portfolio with Best-in-Class Technology Increasingly Used to Diagnose Cancer in Women with Dense Breasts
Company’s Costa Rica and Danbury, CT manufacturing facilities recognized for energy savings and operational efficiency initiatives
Agreement expands reach of industry-leading Horizon DXA system
FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis
Improved accuracy in identifying bacterial vaginosis (BV), vulvovaginal candidiasis (Candida vaginitis, CV) and trichomoniasis (Trichomonas vaginalis, TV) will enable more targeted treatment for women
Hologic, Inc. announced that the Company will present at these upcoming investor conferences
Hologic Showcases Growing Portfolio of Women’s Health Products at 2019 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting
Company to host timely educational panel on breast density featuring leading clinicians
Revenue of $818.4 Million Grows 3.7%, 5.2% in Constant Currency
Hologic Showcases New Breast Surgery Franchise at 20th Annual Meeting of The American Society of Breast Surgeons
Breast health leader will highlight expanding portfolio for breast conserving surgery
Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies